Literature DB >> 23845672

Rarity revisited: cryptococcal peritonitis.

Karim El-Kersh1, Wasiq Faraz Rawasia, Udit Chaddha, Juan Guardiola.   

Abstract

Cryptococcal peritonitis is a rare disease. Although the respiratory tract is considered to be the usual port of entry for the organism, the gastrointestinal tract can also serve as the potential site of entry. Here, we present a case of cryptococcal peritonitis that developed in an HIV-negative patient with underlying liver cirrhosis. We reviewed the literature and a total of 61 cases of cryptococcal peritonitis were identified. Liver cirrhosis, HIV/AIDS and end-stage renal disease on continuous ambulatory peritoneal dialysis were the major risk factors for developing crytococcal peritonitis.

Entities:  

Mesh:

Year:  2013        PMID: 23845672      PMCID: PMC3736299          DOI: 10.1136/bcr-2013-009099

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  50 in total

1.  Hepatic failure as a manifestation of cryptococcosis.

Authors:  S M SABESIN; H J FALLON; V T ANDRIOLE
Journal:  Arch Intern Med       Date:  1963-05

2.  Cryptococcal peritonitis as the first AIDS-defining illness in Zimbabwe.

Authors:  R A Ferrand; A J V Maunganidze; N M Mgodi
Journal:  Trop Doct       Date:  2006-10       Impact factor: 0.731

3.  Cryptococcus laurentii infection complicating peritoneal dialysis.

Authors:  J T Sinnott; J Rodnite; P J Emmanuel; A Campos
Journal:  Pediatr Infect Dis J       Date:  1989-11       Impact factor: 2.129

Review 4.  Spontaneous bacterial peritonitis.

Authors:  C Guarner; G Soriano
Journal:  Semin Liver Dis       Date:  1997       Impact factor: 6.115

5.  Cryptococcus peritonitis.

Authors:  F Wang
Journal:  Singapore Med J       Date:  1988-02       Impact factor: 1.858

Review 6.  Cryptococcus neoformans peritonitis in a patient with alcoholic cirrhosis: case report and review of the literature.

Authors:  Sabine Albert-Braun; F Venema; J Bausch; K-P Hunfeld; V Schäfer
Journal:  Infection       Date:  2005-08       Impact factor: 3.553

7.  Myositis resulting from disseminated cryptococcosis in a patient with hepatitis C cirrhosis.

Authors:  S D Flagg; Y J Chang; C P Masuell; S Natarajan; G Hermann; M H Mendelson
Journal:  Clin Infect Dis       Date:  2001-03-20       Impact factor: 9.079

8.  Cryptococcosis in cirrhotic patients.

Authors:  Alex Vianey Callado França; Marcos Carneiro; Karina dal Sasso; Cacilda da Silva Souza; Ana Martinelli
Journal:  Mycoses       Date:  2005-01       Impact factor: 4.377

Review 9.  Virulence factors of Cryptococcus neoformans.

Authors:  A J Hamilton; J Goodley
Journal:  Curr Top Med Mycol       Date:  1996-12

10.  Cryptococcaemia: clinical features and prognostic factors.

Authors:  S-S Jean; C-T Fang; W-Y Shau; Y-C Chen; S-C Chang; P-R Hsueh; C-C Hung; K-T Luh
Journal:  QJM       Date:  2002-08
View more
  5 in total

1.  Analysis of sphingolipids, sterols, and phospholipids in human pathogenic Cryptococcus strains.

Authors:  Ashutosh Singh; Andrew MacKenzie; Geoffrey Girnun; Maurizio Del Poeta
Journal:  J Lipid Res       Date:  2017-08-15       Impact factor: 5.922

2.  Cirrhosis, gastrointestinal bleed, and cryptococcal peritonitis.

Authors:  Amy E Barnett; Karen B Brust
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-02-11

3.  Cryptococcemia in an HIV-negative patient with decompensated liver cirrhosis.

Authors:  Manasa Kandula; Amar H Kelkar; Nicole Liberio; Meenakshy K Aiyer
Journal:  J Community Hosp Intern Med Perspect       Date:  2016-12-15

4.  Disseminated Cryptococcal Disease in A Patient With Chronic Chylothorax and a Pleurovenous Catheter, a Case Report With Autopsy Findings.

Authors:  William Mundo; Amber Berning; Yiannis Koullias; Daniel B Chastain; Neil Stone; Carlos Franco-Paredes; Andrés F Henao-Martínez; Lilian Vargas Barahona
Journal:  Open Forum Infect Dis       Date:  2021-05-19       Impact factor: 3.835

Review 5.  Immunity to Cryptococcus neoformans and C. gattii during cryptococcosis.

Authors:  Josie F Gibson; Simon A Johnston
Journal:  Fungal Genet Biol       Date:  2014-12-12       Impact factor: 3.495

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.